Prevalence of mild cognitive impairment in surgical menopause: subtypes and associated factors

References

• World Health Organization. Dementia; 2019 [last accessed 2020 Aug 9]. Available from: //www.who.int/news-room/fact-sheets/detail/dementia
   Google Scholar
• Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356.
   PubMed Web of Science ®Google Scholar
• Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447–1455.
   PubMed Web of Science ®Google Scholar
• Morgan KN, Derby CA, Gleason CE. Cognitive changes with reproductive aging, perimenopause, and menopause. Obstet Gynecol Clin North Am. 2018;45:751–763.
   PubMed Web of Science ®Google Scholar
• Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993;336:293–306.
   PubMed Web of Science ®Google Scholar
• Rapp PR, Morrison JH, Roberts JA. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci. 2003;23:5708–5714.
   PubMed Web of Science ®Google Scholar
• Mukai H, Tsurugizawa T, Ogiue-Ikeda M, et al. Local neurosteroid production in the hippocampus: influence on synaptic plasticity of memory. Neuroendocrinology. 2006;84:255–263.
   PubMed Web of Science ®Google Scholar
• Foy MR. Ovarian hormones, aging and stress on hippocampal synaptic plasticity. Neurobiol Learn Mem. 2011;95:134–144.
   PubMed Web of Science ®Google Scholar
• Berent-Spillson A, Persad CC, Love T, et al. Early menopausal hormone use influences brain regions used for visual working memory. Menopause. 2010;17:692–699.
   PubMed Web of Science ®Google Scholar
• Maki PM, Dennerstein L, Clark M, et al. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res. 2011;1379:232–243.
   PubMed Web of Science ®Google Scholar
• Joffe H, Hall JE, Gruber S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006;13:411–422.
   PubMed Web of Science ®Google Scholar
• Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause. 2007;14:572–579.
   PubMed Web of Science ®Google Scholar
• Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses’ health study. Obstet Gynecol. 2013;121:709–716.
   PubMed Web of Science ®Google Scholar
• Fakkert IE, Abma EM, Westrik IG, et al. Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer. Eur J Cancer. 2015;51:400–408.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69:1074–1083.
   PubMed Web of Science ®Google Scholar
• Kengsakul M, Chaikittisilpa S, Hemrungrojn S, et al. The factors associated with mild cognitive impairment (MCI) in surgical menopause women. J Med Assoc Thai. 2015;98:327–333.
   PubMedGoogle Scholar
• Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699.
   PubMed Web of Science ®Google Scholar
• Deetong-On T, Puapornpong P, Pumipichet S, et al. Prevalence and risk factors of mild cognitive impairment in menopausal women at HRH Princess Maha Chakri Sirindhorn medical center. Thai J Obstet Gynecol. 2013;21:110–116.
   Google Scholar
• Georgakis MK, Beskou-Kontou T, Theodoridis I, et al. Surgical menopause in association with cognitive function and risk of dementia: a systematic review and meta-analysis. Psychoneuroendocrinology. 2019;106:9–19.
   PubMed Web of Science ®Google Scholar
• Jongsiriyanyong S, Limpawattana P. Mild cognitive impairment in clinical practice: a review article. Am J Alzheimers Dis Other Demen. 2018;33:500–507.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018;90:126–135.
   PubMed Web of Science ®Google Scholar
• Tangwongchai S, Phanasathit M, Chareonboon T, et al. The validity of Thai version of The Montreal Cognitive Assessment (MoCA-T). Dement Neuropsychol. 2009;3:172–176.
   Google Scholar
• Julayanont P, PPhillips N, Chertkow H, et al. The Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larne AJ, editor. Cognitive screening instruments: a practical approach. London: Springer-Verlag; 2012. p. 111–152.
   Google Scholar
• Julayanont P, Brousseau M, Chertkow H, et al. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer’s disease. J Am Geriatr Soc. 2014;62:679–684.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Shoupe D. Surgical menopause. Endocrinol Metab Clin North Am. 2015;44:531–542.
   PubMed Web of Science ®Google Scholar
• Gholizadeh S, Sadatmahalleh SJ, Ziaei S. The association between estradiol levels and cognitive function in postmenopausal women. IJRM. 2018;16:455–458.
   Google Scholar
• Overton M, Pihlsgard M, Elmstahl S. Prevalence and incidence of mild cognitive impairment across subtypes, age, and sex. Dement Geriatr Cogn Disord. 2019;47:219–232.
   PubMed Web of Science ®Google Scholar
• Baumgart M, Snyder HM, Carrillo MC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11:718–726.
   PubMed Web of Science ®Google Scholar
• Lehert P, Villaseca P, Hogervorst E, et al. Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. Climacteric. 2015;18:678–689.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 2011;1379:188–198.
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651–2662.
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA. 2004;291:2947–2958.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Maki PM, Henderson VW. Hormone therapy, dementia, and cognition: the Women’s Health Initiative 10 years on. Climacteric. 2012;15:256–262.
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Tang MX, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 1998;50:368–373.
   PubMed Web of Science ®Google Scholar
• Hampson E. Estrogens, aging, and working memory. Curr Psychiatry Rep. 2018;20:109.
   PubMed Web of Science ®Google Scholar
• Aggarwal NT, Wilson RS, Beck TL, et al. Mild cognitive impairment in different functional domains and incident Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2005;76:1479–1484.
   PubMed Web of Science ®Google Scholar
• Grober E, Hall CB, Lipton RB, et al. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer’s disease. J Int Neuropsychol Soc. 2008;14:266–278.
   PubMed Web of Science ®Google Scholar
• Huey ED, Manly JJ, Tang MX, et al. Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement. 2013;9:632–639.
   PubMed Web of Science ®Google Scholar
• Ma F, Wu T, Zhao J, et al. Prevalence of mild cognitive impairment and its subtypes among Chinese older adults: role of vascular risk factors. Dement Geriatr Cogn Disord. 2016;41:261–272.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology. 2010;75:889–897.
   PubMed Web of Science ®Google Scholar
• Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav. 2014;66:602–618.
   PubMed Web of Science ®Google Scholar
• Kaur A, Edland SD, Peavy GM. The MoCA-Memory Index Score: an efficient alternative to paragraph recall for the detection of amnestic mild cognitive impairment. Alzheimer Dis Assoc Disord. 2018;32:120–124.
   PubMed Web of Science ®Google Scholar
• Au B, Dale-McGrath S, Tierney MC. Sex differences in the prevalence and incidence of mild cognitive impairment: a meta-analysis. Ageing Res Rev. 2017;35:176–199.
   PubMed Web of Science ®Google Scholar
• Borland E, Nagga K, Nilsson PM, et al. The Montreal Cognitive Assessment: normative data from a large Swedish population-based cohort. JAD. 2017;59:893–901.
   Google Scholar
• McDowell I, Xi G, Lindsay J, et al. Mapping the connections between education and dementia. J Clin Exp Neuropsychol. 2007;29:127–141.
   PubMed Web of Science ®Google Scholar
• Murray AD, Staff RT, McNeil CJ, et al. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer’s diseases. Brain. 2011;134:3687–3696.
   PubMed Web of Science ®Google Scholar
• Wada M, Noda Y, Shinagawa S, et al. Effect of education on Alzheimer’s disease-related neuroimaging biomarkers in healthy controls, and participants with mild cognitive impairment and Alzheimer’s disease: a cross-sectional study. J Alzheimers Dis. 2018;63:861–869.
   PubMed Web of Science ®Google Scholar
• Ritter A, Hawley N, Banks SJ, et al. The association between montreal cognitive assessment memory scores and hippocampal volume in a neurodegenerative disease sample. JAD. 2017;58:695–699.
   Google Scholar